Connext: first virtual pharma software summit for Werum PAS-X users and the pharma & biotech industry


Pharma, biotech and cell & gene companies who use Werum PAS-X MES as well as those who are interested in the use of manufacturing IT and manufacturing intelligence to digitise their production are invited to Connext 2021 – the new virtual Pharma Software Summit by Werum Solutions.

This four-day-conference from 2-5 March 2021 will take place for the first time and as a virtual online event. Accommodations have been made for different time zones in Asia, Europe and the US. Connext is succeeding the yearly PAS-X User Group Meeting (UGM) and the PFU (PAS-X for Us) Meeting.

“We expect pharma and biotech experts from all over the world,” says Jens Woehlbier, Chief Executive Officer (CEO) Software, Körber Business Area Pharma. “Together, they form the world's largest pharma software community! Join us, connect yourself and learn how our Körber software solutions help digitize your pharma, biotech and cell & gene therapy production.”

Under the motto “Elevating your business. Together.”, Connext offers a comprehensive program of best-practice user presentations, workshops, product demonstrations, panel discussions and online networking opportunities to get attendees connected:

  • Products + Solutions
    Stay up to date on the latest PAS-X manufacturing IT solutions to save time & effort and avoid risk in pharmaceutical production
  • Best Practices + Insights
    Learn from PAS-X customer cases by Bayer, Boehringer Ingelheim, Regeneron and SteriPack and PAS-X user panel discussions with Amazon Web Services, Johnson & Johnson und Lyell
  • Workshops + Insights
    Select from different manufacturing topics, discuss the challenges in daily work and strategize the solutions
  • Thoughts + Opinions
    Join industry thought leader discussions with AstraZeneca, Bayer, Novartis, Takeda and Vetter Pharma
  • Experts + Exchange
    Network with Körber’s pharma software experts and peers in virtual rooms

Add a Comment

No messages on this article yet

Editorial: +44 (0)1892 536363
Publisher: +44 (0)208 440 0372
Subscribe FREE to the weekly E-newsletter